Kimberly-Clark is buying Tylenol-maker Kenvue in a cash and stock deal worth about $48.7B. It will put Kleenex, Band-Aid and more under one roof.
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7B consumer brands deal
CHICAGO — Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.
The combined company will have a huge stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and Band-Aid side-by-side with Kimberly-Clark’s Cottonelle toilet paper, Huggies and Kleenex tissues. It will also generate about $32 billion in annual revenue.
Kenvue has spent a relatively brief period as an independent company, having been spun off by Johnson & Johnson two years ago. J &J first announced in late 2021 that it was splitting its slow-growth consumer health division from the pharmaceutical and medical device divisions.
Kenvue has since been targeted by activist investors unhappy about the trajectory of the company and Wall Street appeared to anticipate some heavy lifting ahead for Kimberly-Clark.
Shares of Kimberly-Clark, based in just outside of Dallas, slumped more than 13% on Monday. Kenvue’s stock jumped more than 14%.
Kenvue and Tylenol have been thrust into the national spotlight this year as President Donald Trump and Health Secretary Robert F.
